Localization of the carbohydrate recognition sites of the insulin-like growth factor II/mannose 6-phosphate receptor to domains 3 and 9 of the extracytoplasmic region

被引:43
作者
Hancock, MK [1 ]
Yammani, RD [1 ]
Dahms, NM [1 ]
机构
[1] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
关键词
D O I
10.1074/jbc.M208534200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The insulin-like growth factor II/mannose 6-phosphate receptor is a multifunctional receptor that binds to a diverse array of mannose 6-phosphate (Man-6-P) modified proteins as well as nonglycosylated ligands. Previous studies have mapped its two Man-6-P binding sites to a minimum of three domains, 1-3 and 7-9, within its 15-domain extracytoplasmic region. Since the primary amino acid determinants of carbohydrate recognition by the insulin-like growth factor II/mannose 6-phosphate receptor are predicted by sequence alignment to the cation-dependent mannose 6-phosphate receptor to reside within domains 3 and 9, constructs encoding either domain 3 alone or domain 9 alone were expressed in a Pichia pastoris expression system and tested for their ability to bind several carbohydrate ligands, including Man-6-P, pentamannosyl phosphate, the lysosomal enzyme, beta-glucuronidase, and the carbohydrate modifications (mannose 6-sulfate and Man-6-P methyl ester) found on Dictyostelium discoideum lysosomal enzymes. Although both constructs were functional in ligand binding and dissociation, these studies demonstrate the ability of domain 9 alone to fold into a high affinity (K-d=0.3+/-0.1 nM) carbohydrate-recognition domain whereas the domain 3 alone construct is capable of only low affinity binding (K(d)similar to500 nM) toward beta-glucuronidase, suggesting that residues in adjacent domains (domains 1 and/or 2) are important, either directly or indirectly, for optimal binding by domain 3.
引用
收藏
页码:47205 / 47212
页数:8
相关论文
共 70 条
[1]   The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor [J].
Blanchard, F ;
Raher, S ;
Duplomb, L ;
Vusio, P ;
Pitard, V ;
Taupin, JL ;
Moreau, JF ;
Hoflack, B ;
Minvielle, S ;
Jacques, Y ;
Godard, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :20886-20893
[2]  
BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642
[3]   Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur [J].
Brown, J ;
Esnouf, RM ;
Jones, MA ;
Linnell, J ;
Harlos, K ;
Hassan, AB ;
Jones, EY .
EMBO JOURNAL, 2002, 21 (05) :1054-1062
[4]  
BRUNETTI CR, 1994, J BIOL CHEM, V269, P17067
[5]   2 PROTEINS TARGETED TO THE SAME LYTIC GRANULE COMPARTMENT UNDERGO VERY DIFFERENT POSTTRANSLATIONAL PROCESSING [J].
BURKHARDT, JK ;
HESTER, S ;
ARGON, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :7128-7132
[6]   Mechanisms for high affinity mannose 6-phosphate ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor - Negative cooperactivity and receptor oligomerization [J].
Byrd, JC ;
MacDonald, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (25) :18638-18646
[7]   Dimerization of the insulin-like growth factor II/mannose 6-phosphate receptor [J].
Byrd, JC ;
Park, JHY ;
Schaffer, BS ;
Garmroudi, F ;
MacDonald, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (25) :18647-18656
[8]   Human DNase I contains mannose 6-phosphate and binds the cation-independent mannose 6-phosphate receptor [J].
Cacia, J ;
Quan, CP ;
Pai, R ;
Frenz, J .
BIOCHEMISTRY, 1998, 37 (43) :15154-15161
[9]   Heterologous protein expression in the methylotrophic yeast Pichia pastoris [J].
Cereghino, JL ;
Cregg, JM .
FEMS MICROBIOLOGY REVIEWS, 2000, 24 (01) :45-66
[10]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099